Clinical Trials
8
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)β’ Click on a phase to view related trials
A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.
- Conditions
- Hepatitis B
- First Posted Date
- 2002-08-21
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Triangle Pharmaceuticals
- Target Recruit Count
- 30
- Registration Number
- NCT00044135
- Locations
- πΊπΈ
University of Illinois at Chicago, Chicago, Illinois, United States
πΊπΈThomas Jefferson University Hospital, Jefferson Medical College, Philadelphia, Pennsylvania, United States
π¨π¦Viridae, Vancouver, Canada
A Randomized, Double-Blind Study of MKC-442 Combined With Viracept in Patients Who Are Epivir + Retrovir Experienced and Are Protease Inhibitor- and Non-Nucleoside Reverse Transcriptase Inhibitor-Naive
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Triangle Pharmaceuticals
- Registration Number
- NCT00002215
- Locations
- πΊπΈ
Anderson Clinical Research, Pittsburgh, Pennsylvania, United States
Comparing FTC and Lamivudine in HIV-Infected Patients on a Stable Anti-HIV Drug Combination
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Triangle Pharmaceuticals
- Target Recruit Count
- 390
- Registration Number
- NCT00002416
- Locations
- πΊπΈ
Dr Robert Wallace, St. Petersburg, Florida, United States
πΊπΈNorth Shore Univ Hosp, Great Neck, New York, United States
A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Triangle Pharmaceuticals
- Registration Number
- NCT00002362
- Locations
- πΊπΈ
Ctr for AIDS Research / Education and Service (CARES), Sacramento, California, United States
πΊπΈSan Francisco Veterans Administration Med Ctr, San Francisco, California, United States
πΊπΈGary Richmond MD, Fort Lauderdale, Florida, United States
Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Triangle Pharmaceuticals
- Target Recruit Count
- 100
- Registration Number
- NCT00017992
- Locations
- πΊπΈ
USC School of Medicine / LA County Med Ctr, Los Angeles, California, United States
πΊπΈUniv of Florida Health Science Ctr / Pediatrics, Jacksonville, Florida, United States
πΊπΈUniv of Miami, Miami, Florida, United States
- Prev
- 1
- 2
- Next